From Yahoo Finance · · 1m 30s
Alluvium Bets on HCA Healthcare After 17.5% Plunge
A global fund manager sees opportunity in a hospital operator's sharp selloff, buying more shares despite broader market headwinds.
In brief
A global fund manager sees opportunity in a hospital operator's sharp selloff, buying more shares despite broader market headwinds. Alluvium increased its HCA Healthcare position when the stock fell sharply on lower-than-expected respiratory volumes, betting the market overreacted to temporary flu season weakness…
Global fund stumbles despite market rally
Alluvium's Conventum Global Fund fell 1.4% in euros during Q2 2026, even as semiconductors led a powerful equity rally. Cable and healthcare holdings dragged on performance.
HCA Healthcare drops 17.5% in one quarter
HCA Healthcare, a major hospital operator, fell 17.5% in Q2 2026. The stock dropped another 8.8% right after the company reported first-quarter results, even though management reaffirmed its full-year guidance.
“The share price fell 8.8% immediately following its first quarter results (despite management reaffirming its 2026 guidance).”
Mild flu season blamed for selloff

Alluvium suspects the stock plunge was an overreaction to lower-than-expected respiratory volumes from a mild flu season. The fund saw this as a temporary issue, not a fundamental business problem.
“We suspect this is a (over) reaction to poorer than expected respiratory volumes due to a mild flu season.”
Fund increases HCA position at discount
With HCA Healthcare shares trading below Alluvium's valuation estimate, the fund bought more stock. The position grew to 6.4% of the portfolio, betting the market would eventually recognize the company's value.
“With the shares trading at a discount to our valuation we bought a little more to bring the Fund's position to 6.4%.”
HCA stock shows modest recent gains
HCA Healthcare closed at $423.04 per share on September 15, 2026, up 3.93% over the past month and 5.92% over the past year. The company has a market cap of $91.76 billion.
Here's the gist
Alluvium increased its HCA Healthcare position when the stock fell sharply on lower-than-expected respiratory volumes, betting the market overreacted to temporary flu season weakness.





